Roman DBDR Acquisition Corp. II
NASDAQ:DRDBFinancial - Conglomerates
-$0.01 today
- Market cap
- $248.86M
- Beta
- 0.01
- P/E (TTM)
- 45.8
- EPS (TTM)
- $0.23
Volume 0.00M
Average 0.12M
DRDB Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Roman DBDR Acquisition Corp. IINASDAQ: DRDB
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents falls 94.4% from a year ago
Cash & equivalents stood at $53.49K at the end of Q1 FY2026, down 94.4% from a year earlier and down 70.8% from the prior quarter.
Context
- Cash & equivalents amounted to 0.0% of total assets at the end of Q1 FY2026, down 0.4 pp from a year earlier.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -94.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 183.02K USD
- Year-over-year change
- -85.6%
- 1-year CAGR
- -85.6%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 183.02K | -85.6% |
| FY2024 | 2024-12-31 | 1.27M | — |
Cash & Equivalents vs competitors
How DRDB compares with its peers on the latest reported figures
- DRDB's Mar 2026 cash & equivalents of $53.49K is the 8th highest of the 10 companies compared; the peer median is $155.43K.
- Its year-over-year change of -94.4% is the 8th highest of 9, against a peer median of -79.6%.
- Cash & equivalents amounts to 0.0% of total assets for DRDB, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $653.38K | — | -0.8% | 0.3% | |
NTWONewbury Street II Acquisition Corp | Mar 2026 | $497.39K | -55.9% | — | 0.3% |
| Mar 2026 | $412.91K | -66.2% | +95.5% | 0.2% | |
| Mar 2026 | $323.22K | -84.2% | — | 0.2% | |
| Mar 2026 | $155.43K | -85.0% | — | 0.1% | |
POLEAndretti Acquisition Corp. II | Mar 2026 | $150.52K | -75.4% | — | 0.1% |
| Mar 2026 | $93.51K | -83.8% | — | 0.1% | |
DRDBRoman DBDR Acquisition Corp. II | Mar 2026 | $53.49K | -94.4% | — | 0.0% |
| Mar 2026 | $14.89K | +1512.9% | — | 0.0% | |
| Mar 2026 | $4.39K | -99.3% | — | 0.0% | |
HVMCUHighview Merger Corp. Units | — | — | — | — | — |
| Peer median (excluding DRDB) | $155.43K | -79.6% | +47.4% | 0.1% | |
Competitors are the stored peer set for DRDB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|
| Cash & Equivalents | 1.27M | 183.02K |
| Short-term Investments | 0 | 0 |
| Net Receivables | 0 | 9.27K |
| Inventory | 0 | 0 |
| Other Current Assets | 0 | 0 |
| Total Current Assets | 1.4M | 317.71K |
| Property, Plant & Equipment (Net) | 0 | 0 |
| Goodwill | 0 | 0 |
| Intangible Assets | 0 | 0 |
| Long-term Investments | 201.32M | 241.19M |
| Tax Assets | 0 | 0 |
| Other Non-current Assets | 201.42M | 0 |
| Total Non-current Assets | 201.42M | 241.19M |
| Total Assets | 202.81M | 241.51M |
| Account Payables | 0 | 0 |
| Short-term Debt | 0 | 0 |
| Tax Payables | 0 | 0 |
| Deferred Revenue | 0 | 0 |
| Other Current Liabilities | 279.23K | 895.81K |
| Total Current Liabilities | 301.82K | 895.81K |
| Long-term Debt | 0 | 200K |
| Deferred Tax Liabilities | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 |
| Total Non-current Liabilities | 0 | 200K |
| Total Liabilities | 301.82K | 1.1M |
| Common Stock | 201.32M | 241.19M |
| Retained Earnings | 223.46K | (778.86K) |
| Accumulated OCI | 0 | 0 |
| Other Stockholders Equity | 0 | 0 |
| Minority Interest | 0 | 0 |
| Total Equity | 202.51M | 240.41M |
| Total Debt | 0 | 200K |
| Net Debt | (1.27M) | 16.98K |
Roman DBDR Acquisition Corp. II
NASDAQ:DRDB
Intrinsic Alpha fair value
Locked
Current Price
$10.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.